These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
26. Ovarian cancer: diagnosis using 123I monoclonal antibody in comparison with surgical findings. Granowska M; Shepherd J; Britton KE; Ward B; Mather S; Taylor-Papadimitriou J; Epenetos AA; Carroll MJ; Nimmon CC; Hawkins LA Nucl Med Commun; 1984 Aug; 5(8):485-99. PubMed ID: 6533499 [No Abstract] [Full Text] [Related]
27. Antibody-guided irradiation of malignant lesions: three cases illustrating a new method of treatment. A report from the Hammersmith Oncology Group and the Imperial Cancer Research Fund. Lancet; 1984 Jun; 1(8392):1441-3. PubMed ID: 6145882 [TBL] [Abstract][Full Text] [Related]
28. The immunobiology and immunotherapy of ovarian cancer. Bookman MA; Bast RC Semin Oncol; 1991 Jun; 18(3):270-91. PubMed ID: 1710393 [TBL] [Abstract][Full Text] [Related]
29. Therapeutic intraperitoneal 32P: a clinical assessment of the dynamics of distribution. Kaplan WD; Zimmerman RE; Bloomer WD; Knapp RC; Adelstein SJ Radiology; 1981 Mar; 138(3):683-8. PubMed ID: 7465847 [TBL] [Abstract][Full Text] [Related]
30. [Guidelines for external radiotherapy and brachytherapy: introduction to the 2nd edition. Société française de radiothérapie oncologique (SFRO)]. Mahé MA; Barillot I; Chauvet B Cancer Radiother; 2014 Oct; 18(5-6):356-9. PubMed ID: 25199866 [TBL] [Abstract][Full Text] [Related]
31. Common epithelial cancer of the ovary (2). Richardson GS; Scully RE; Nikrui N; Nelson JH N Engl J Med; 1985 Feb; 312(8):474-83. PubMed ID: 3881673 [No Abstract] [Full Text] [Related]
33. [Standards, options, and recommendations for the radiotherapy of patients with endometrial cancer. FNCLCC (National Federation of Cancer Campaign Centers) and CRLCC (Regional Cancer Campaign Centers)]. Thomas L; Bataillard A; Brémond A; Fondrinier E; Fervers B; Achard JL; Lansac J; Bailly C; Hoffstetter S; Basuyau JP; d'Anjou J; Descamps P; Farsi F; Guastalla JP; Laffargue F; Rodier JF; Vincent P; Pigneux J Cancer Radiother; 2001 Apr; 5(2):163-92. PubMed ID: 11355582 [TBL] [Abstract][Full Text] [Related]
34. Rational combinations of immunotherapy with radiotherapy in ovarian cancer. Herrera FG; Irving M; Kandalaft LE; Coukos G Lancet Oncol; 2019 Aug; 20(8):e417-e433. PubMed ID: 31364594 [TBL] [Abstract][Full Text] [Related]
35. Early results of the monoclonal antibody OVTL3 in specific detection of ovarian cancer. Epenetos AA; Lavender JP; Kenemans P; Poels L J Clin Oncol; 1987 Jan; 5(1):160. PubMed ID: 3806157 [No Abstract] [Full Text] [Related]
36. Radiation therapy in the treatment of patients with cancer of the ovary. Bush RS Bull N Y Acad Med; 1983 Oct; 59(8):691-710. PubMed ID: 6357333 [No Abstract] [Full Text] [Related]
37. [REGAJ diagnosis of recurrence of ovarian cancer]. Paterok EM; Jäger W; Feistel H; Lang N; Wolf F Gynakol Rundsch; 1989; 29 Suppl 2():360-3. PubMed ID: 2613050 [No Abstract] [Full Text] [Related]
38. Radioisotopes in treatment of stage Ia ovarian cancer. Buchsbaum HJ; Keettel WC Natl Cancer Inst Monogr; 1975 Oct; 42():127-8. PubMed ID: 1234628 [TBL] [Abstract][Full Text] [Related]
39. Immunopharmacokinetics of 111In-CYT-103 in ovarian cancer patients. Jusko WJ; Kung LP; Schmelter RF Targeted Diagn Ther; 1992; 6():177-90. PubMed ID: 1576345 [No Abstract] [Full Text] [Related]
40. Antitumor antibodies for immunotherapy of ovarian carcinomas. Wagner U Hybridoma; 1993 Oct; 12(5):521-8. PubMed ID: 8300125 [No Abstract] [Full Text] [Related] [Previous] [Next] [New Search]